Clinical Microbiology Market Research Report by Product (Laboratory Instruments, Microbiology Analyzers, and Reagents), by Source (Bloodstream Infections, Gastrointestinal Diseases, and Periodontal Diseases), by End User, by Application, by State (Califor

Clinical Microbiology Market Research Report by Product (Laboratory Instruments, Microbiology Analyzers, and Reagents), by Source (Bloodstream Infections, Gastrointestinal Diseases, and Periodontal Diseases), by End User, by Application, by State (California, Florida, and Illinois) - United States Forecast to 2026 - Cumulative Impact of COVID-19

The United States Clinical Microbiology Market size was estimated at USD 811.07 million in 2020 and expected to reach USD 939.43 million in 2021, at a CAGR 13.01% to reach USD 1,689.72 million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.


Market Segmentation & Coverage:

This research report categorizes the Clinical Microbiology to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the market was studied across Laboratory Instruments, Microbiology Analyzers, and Reagents.

Based on Source, the market was studied across Bloodstream Infections, Gastrointestinal Diseases, Periodontal Diseases, Respiratory Diseases, Sexually Transmitted Diseases, and Urinary Tract Infections.

Based on End User, the market was studied across Academic & Research Institutes, Hospitals & Care Providers, Infectious Diseases, Laboratories, and Patient Self-Testing.

Based on Application, the market was studied across Autoimmune Diseases, Cardiology, Diabetes, Drug Testing, HIV/Aids, Infectious Diseases, Nephrology, and Oncology.

Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Clinical Microbiology Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Clinical Microbiology Market, including Abbott Laboratories, Agilent Technologies, Inc, Alere Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, BIOTECHNOLOGY SOLUTIONS TX, LLC, Bruker Corporation, Cepheid, Danaher Corporation, Hardy Diagnostics, Hologic, Inc., Liofilchem S.r.l., Merck KGaA, Neogen Corporation, QIAGEN, Inc., Rapid Micro Biosystems, Inc., Roche Diagnostics Corporation, Shimadzu Corporation, TCS Biosciences Ltd., The 3M Company, and Thermo Fisher Scientific, Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Clinical Microbiology Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Clinical Microbiology Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Clinical Microbiology Market?
4. What is the competitive strategic window for opportunities in the United States Clinical Microbiology Market?
5. What are the technology trends and regulatory frameworks in the United States Clinical Microbiology Market?
6. What is the market share of the leading vendors in the United States Clinical Microbiology Market?
7. What modes and strategic moves are considered suitable for entering the United States Clinical Microbiology Market?


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. Introduction
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges
6. Clinical Microbiology Market, by Product
6.1. Introduction
6.2. Laboratory Instruments
6.3. Microbiology Analyzers
6.4. Reagents
7. Clinical Microbiology Market, by Source
7.1. Introduction
7.2. Bloodstream Infections
7.3. Gastrointestinal Diseases
7.4. Periodontal Diseases
7.5. Respiratory Diseases
7.6. Sexually Transmitted Diseases
7.7. Urinary Tract Infections
8. Clinical Microbiology Market, by End User
8.1. Introduction
8.2. Academic & Research Institutes
8.3. Hospitals & Care Providers
8.4. Infectious Diseases
8.5. Laboratories
8.6. Patient Self-Testing
9. Clinical Microbiology Market, by Application
9.1. Introduction
9.2. Autoimmune Diseases
9.3. Cardiology
9.4. Diabetes
9.5. Drug Testing
9.6. HIV/Aids
9.7. Infectious Diseases
9.8. Nephrology
9.9. Oncology
10. California Clinical Microbiology Market
11. Florida Clinical Microbiology Market
12. Illinois Clinical Microbiology Market
13. New York Clinical Microbiology Market
14. Ohio Clinical Microbiology Market
15. Pennsylvania Clinical Microbiology Market
16. Texas Clinical Microbiology Market
17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis
17.3. Market Share Analysis, By Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion
18. Company Usability Profiles
18.1. Abbott Laboratories
18.2. Agilent Technologies, Inc
18.3. Alere Inc.
18.4. Becton, Dickinson and Company
18.5. Bio-Rad Laboratories, Inc.
18.6. bioMérieux SA
18.7. BIOTECHNOLOGY SOLUTIONS TX, LLC
18.8. Bruker Corporation
18.9. Cepheid
18.10. Danaher Corporation
18.11. Hardy Diagnostics
18.12. Hologic, Inc.
18.13. Liofilchem S.r.l.
18.14. Merck KGaA
18.15. Neogen Corporation
18.16. QIAGEN, Inc.
18.17. Rapid Micro Biosystems, Inc.
18.18. Roche Diagnostics Corporation
18.19. Shimadzu Corporation
18.20. TCS Biosciences Ltd.
18.21. The 3M Company
18.22. Thermo Fisher Scientific, Inc.
19. Appendix
19.1. Discussion Guide
19.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 3. UNITED STATES CLINICAL MICROBIOLOGY MARKET: MARKET DYNAMICS
FIGURE 4. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 5. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2026
FIGURE 7. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY LABORATORY INSTRUMENTS, 2018-2026 (USD MILLION)
FIGURE 8. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY LABORATORY INSTRUMENTS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 9. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY MICROBIOLOGY ANALYZERS, 2018-2026 (USD MILLION)
FIGURE 10. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY MICROBIOLOGY ANALYZERS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 11. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY REAGENTS, 2018-2026 (USD MILLION)
FIGURE 12. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY REAGENTS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 13. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SOURCE, 2020 VS 2026 (%)
FIGURE 14. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SOURCE, 2020 VS 2026 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SOURCE, 2026
FIGURE 16. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOODSTREAM INFECTIONS, 2018-2026 (USD MILLION)
FIGURE 17. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOODSTREAM INFECTIONS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 18. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY GASTROINTESTINAL DISEASES, 2018-2026 (USD MILLION)
FIGURE 19. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 20. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PERIODONTAL DISEASES, 2018-2026 (USD MILLION)
FIGURE 21. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PERIODONTAL DISEASES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 22. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY RESPIRATORY DISEASES, 2018-2026 (USD MILLION)
FIGURE 23. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY RESPIRATORY DISEASES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 24. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, 2018-2026 (USD MILLION)
FIGURE 25. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 26. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY URINARY TRACT INFECTIONS, 2018-2026 (USD MILLION)
FIGURE 27. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY URINARY TRACT INFECTIONS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 28. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 29. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY END USER, 2026
FIGURE 31. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2026 (USD MILLION)
FIGURE 32. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 33. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, 2018-2026 (USD MILLION)
FIGURE 34. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 35. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2026 (USD MILLION)
FIGURE 36. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 37. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY LABORATORIES, 2018-2026 (USD MILLION)
FIGURE 38. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY LABORATORIES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 39. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PATIENT SELF-TESTING, 2018-2026 (USD MILLION)
FIGURE 40. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PATIENT SELF-TESTING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 41. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 42. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 43. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2026
FIGURE 44. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2026 (USD MILLION)
FIGURE 45. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 46. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY CARDIOLOGY, 2018-2026 (USD MILLION)
FIGURE 47. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY CARDIOLOGY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 48. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY DIABETES, 2018-2026 (USD MILLION)
FIGURE 49. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY DIABETES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 50. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY DRUG TESTING, 2018-2026 (USD MILLION)
FIGURE 51. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY DRUG TESTING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 52. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY HIV/AIDS, 2018-2026 (USD MILLION)
FIGURE 53. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY HIV/AIDS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 54. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2026 (USD MILLION)
FIGURE 55. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 56. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY NEPHROLOGY, 2018-2026 (USD MILLION)
FIGURE 57. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY NEPHROLOGY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 58. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, 2018-2026 (USD MILLION)
FIGURE 59. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 60. UNITED STATES CLINICAL MICROBIOLOGY MARKET: FPNV POSITIONING MATRIX
FIGURE 61. UNITED STATES CLINICAL MICROBIOLOGY MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 62. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES CLINICAL MICROBIOLOGY MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES CLINICAL MICROBIOLOGY MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY LABORATORY INSTRUMENTS, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY MICROBIOLOGY ANALYZERS, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY REAGENTS, BY STATE, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SOURCE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOODSTREAM INFECTIONS, BY STATE, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY STATE, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PERIODONTAL DISEASES, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY RESPIRATORY DISEASES, BY STATE, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, BY STATE, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY URINARY TRACT INFECTIONS, BY STATE, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY STATE, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY STATE, 2018-2026 (USD MILLION)
TABLE 18. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY STATE, 2018-2026 (USD MILLION)
TABLE 19. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY LABORATORIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 20. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PATIENT SELF-TESTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 21. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 22. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY STATE, 2018-2026 (USD MILLION)
TABLE 23. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY CARDIOLOGY, BY STATE, 2018-2026 (USD MILLION)
TABLE 24. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY DIABETES, BY STATE, 2018-2026 (USD MILLION)
TABLE 25. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY DRUG TESTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 26. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY HIV/AIDS, BY STATE, 2018-2026 (USD MILLION)
TABLE 27. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY STATE, 2018-2026 (USD MILLION)
TABLE 28. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY NEPHROLOGY, BY STATE, 2018-2026 (USD MILLION)
TABLE 29. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY STATE, 2018-2026 (USD MILLION)
TABLE 30. UNITED STATES CLINICAL MICROBIOLOGY MARKET: SCORES
TABLE 31. UNITED STATES CLINICAL MICROBIOLOGY MARKET: BUSINESS STRATEGY
TABLE 32. UNITED STATES CLINICAL MICROBIOLOGY MARKET: PRODUCT SATISFACTION
TABLE 33. UNITED STATES CLINICAL MICROBIOLOGY MARKET: RANKING
TABLE 34. UNITED STATES CLINICAL MICROBIOLOGY MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 35. UNITED STATES CLINICAL MICROBIOLOGY MARKET: MERGER & ACQUISITION
TABLE 36. UNITED STATES CLINICAL MICROBIOLOGY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 37. UNITED STATES CLINICAL MICROBIOLOGY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 38. UNITED STATES CLINICAL MICROBIOLOGY MARKET: INVESTMENT & FUNDING
TABLE 39. UNITED STATES CLINICAL MICROBIOLOGY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 40. UNITED STATES CLINICAL MICROBIOLOGY MARKET: LICENSE & PRICING

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook